Hibiscus sabdariffa/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Hibiscus sabdariffa — no detected effect on C-reactive protein concentration
Evidence strength: moderate.FindingNull resultreplicated ×1“The levels of CRP (: n=4; pooled SMD: 0.05; 95% CI: -0.26, 0.36; P = 0.75), IL-10 (: n=4; pooled SMD:-0.38; 95% CI: -1.67, 0.91; P = 0.56), and iNOS (: n=2; pooled SMD:-0.69; 95% CI: -1.60, 0.23 P = 0.14) were not significantly affected by HS treatment.”
Quoted verbatim from Immunomodulatory and Mechanistic Considerations of Hibiscus sabdariffa (HS) in Dysfunctional Immune Responses: A Systematic Review.. - Study
- meta-analysis
- Population
- Four included studies of Hibiscus sabdariffa calyx extract against untreated control groups; the review's Table 2 lists the CRP studies as healthy humans, humans with metabolic syndrome and men at low cardiovascular risk
Effect 0.05 standardised mean difference, 95% CI -0.26 to 0.36
Immunomodulatory and Mechanistic Considerations of Hibiscus sabdariffa (HS) in Dysfunctional Immune Responses: A Systematic Review.2021PMID:3404060010.3389/fimmu.2021.550670Permalink
To cite this finding: https://catalystproject.ai/e/01M5MH2BGK8JNMJR9FEVH2YX1E